Alahist D Tablet
NDC Package 50991-776-01

View Billable Units, 11-Digit Conversion Format, and RxNorm mappings

Package Information

Alahist D (pheniramine maleate, phenylephrine hcl) tablets is directionsAdults and children 12 years of age and over1 tablet every 4 hours, not to exceed 6 tablets in 24 hoursChildren 6 to under 12 years of ageChildren under 6 consult a doctor1/2 tablet every 4 hours, not to exceed 3 tablets in 24 hours. This formulation utilizes a tablet delivery system. Marketed by Poly Pharmaceuticals, Inc., this product is identified by NDC 50991-776 and is authorized under FDA application M012.

Identification & Billing

NDC Package Code
50991-776-01
Package Description
100 TABLET in 1 BOTTLE
Product Code
11-Digit Billing Format
50991077601
Billing Unit
EA - Billing unit of "each" is used when the product is dispensed in discreet units.
Units Per Package
100 EA
RxNorm Crosswalk
  • RxCUI: 2286592 - pheniramine maleate 17.5 MG / phenylephrine HCl 10 MG Oral Tablet
  • RxCUI: 2286592 - pheniramine maleate 17.5 MG / phenylephrine hydrochloride 10 MG Oral Tablet
  • RxCUI: 2286598 - ALAHIST D 17.5 MG / 10 MG Oral Tablet
  • RxCUI: 2286598 - pheniramine maleate 17.5 MG / phenylephrine hydrochloride 10 MG Oral Tablet [Alahist D]
  • RxCUI: 2286598 - Alahist D (pheniramine maleate 17.5 MG / phenylephrine HCl 10 MG) Oral Tablet

Clinical Specifications

Proprietary Name
Alahist D
Non-Proprietary Name
Pheniramine Maleate, Phenylephrine Hcl
Substance Name
Pheniramine Maleate; Phenylephrine Hydrochloride
Dosage Form
Tablet - A solid dosage form containing medicinal substances with or without suitable diluents.
Administration Route
Oral - Administration to or by way of the mouth.
Usage Information
DirectionsAdults and children 12 years of age and over1 tablet every 4 hours, not to exceed 6 tablets in 24 hoursChildren 6 to under 12 years of ageChildren under 6 consult a doctor1/2 tablet every 4 hours, not to exceed 3 tablets in 24 hours

Regulatory & Marketing

Labeler Name
Poly Pharmaceuticals, Inc.
Product Type
Human Otc Drug
FDA Application #
M012
Marketing Category
OTC MONOGRAPH DRUG -
Start Marketing Date
04-01-2020
Listing Expiration
12-31-2026
Exclude Flag
N
Sample Package
No

Hierarchy Structure

Code Lineage

The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.

* Please review the full disclaimer at the bottom of this page.

Other Available Packages

The following commercial packages are registered under the same Product NDC (50991-776). Click a package code to view its specific billing and regulatory data.

12 TABLET in 1 BLISTER PACK

* Please review the full disclaimer at the bottom of this page.

Frequently Asked Questions

What is the distribution configuration for this product package?

The code 50991-776-01 identifies a specific commercial package of 100 tablet in 1 bottle of Alahist D, a human over the counter drug labeled by Poly Pharmaceuticals, Inc.. This product is billed for "EA" each discreet unit and contains an estimated amount of 100 billable units per package. This tablet is formulated for oral use and contains pheniramine maleate; phenylephrine hydrochloride as the active substance.

Is this product currently listed with the FDA?

Yes, this product is active and verified within the NDC Directory. It was introduced to the market by Poly Pharmaceuticals, Inc. on April 01, 2020. The current certification is valid through December 31, 2026.

How is this Poly Pharmaceuticals, Inc. product billed for insurance claims?

For medical billing and reimbursement, this package follows the 11-digit CMS format: 50991077601. Quantities are measured in per "each", products billed on a per each basis are usually products dispensed in discreet units.. There are 100 total billable units per package. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.

11-Digit Code Conversion

Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:

10-Digit Format (5-3-2)
50991-776-01
11-Digit CMS (5-4-2)
50991-0776-01

Note: The zero is added to the Product segment to maintain the 5-4-2 structure.